O'Brien S - Search Results

1

Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review.

Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Wyatt K, et al. BMJ. 2001 Oct 6;323(7316):776-80. doi: 10.1136/bmj.323.7316.776. BMJ. 2001. PMID: 11588078 Free PMC article.

2

Prescribing patterns in premenstrual syndrome.

Wyatt KM, Dimmock PW, Frischer M, Jones PW, O'Brien SP. Wyatt KM, et al. BMC Womens Health. 2002 Jun 19;2(1):4. doi: 10.1186/1472-6874-2-4. BMC Womens Health. 2002. PMID: 12086594 Free PMC article.

3

Premenstrual syndrome: diagnosis and intervention.

Ugarriza DN, Klingner S, O'Brien S. Ugarriza DN, et al. Nurse Pract. 1998 Sep;23(9):40, 45, 49-52 passim. Nurse Pract. 1998. PMID: 9778669 Review.

4

Premenstrual tension syndrome.

O'Brien S. O'Brien S. Br Med J. 1979 Mar 17;1(6165):754. doi: 10.1136/bmj.1.6165.754. Br Med J. 1979. PMID: 571304 Free PMC article. No abstract available.

5

[Controversies on the etiology and treatment of the premenstrual syndrome].

O'Brien S. O'Brien S. Recenti Prog Med. 1984 Feb;75(2):151-67. Recenti Prog Med. 1984. PMID: 6539492 Italian. No abstract available.

6

Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.

Ruhluel D, Fisher L, Barton TE, Leighton H, Kumar S, Morillo PA, O'Brien S, Fothergill JL, Neill DR. Ruhluel D, et al. Among authors: o brien s. ISME J. 2024 Apr 22:wrae065. doi: 10.1093/ismejo/wrae065. Online ahead of print. ISME J. 2024. PMID: 38647527

7

Management of Dry Eye Toxicity After Treatment with ¹⁷⁷Lu-PSMA-617 Radioligand Therapy.

Pepin A, Lee V, O'Brien S, Mulugeta P, Taunk NK. Pepin A, et al. Among authors: o brien s. Pract Radiat Oncol. 2024 Apr 15:S1879-8500(24)00079-1. doi: 10.1016/j.prro.2024.04.001. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 38631608

8

Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.

Pracoń R, Spertus JA, Broderick S, Bangalore S, Rockhold FW, Ruzyllo W, Demchenko E, Nageh T, Grossman GB, Mavromatis K, Manjunath CN, Smanio PEP, Stone GW, Mancini GBJ, Boden WE, Newman JD, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Pracoń R, et al. Circ Cardiovasc Interv. 2024 Apr 17:e013435. doi: 10.1161/CIRCINTERVENTIONS.123.013435. Online ahead of print. Circ Cardiovasc Interv. 2024. PMID: 38629312

9

Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT.

O'Brien S, Musameh K, El Obeid M, Butler T, Armstrong M, Cunningham Z, Atzinger A, Kuwert T, Mitchell PD, Donnelly SC. O'Brien S, et al. QJM. 2024 Apr 12:hcae067. doi: 10.1093/qjmed/hcae067. Online ahead of print. QJM. 2024. PMID: 38608203 No abstract available.

10

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.

Zhao Y, Laird AD, Roberts KG, Yafawi RL, Kantarjian HM, DeAngelo DJ, Stelljes M, Liedtke M, Stock W, Gökbuget N, O'Brien SM, Jabbour EJ, Cassaday RD, Loyd MR, Olsen SR, Neale GA, Liu X, Vandendries E, Advani AS, Mullighan CG. Zhao Y, et al. Among authors: o brien sm. Blood Adv. 2024 Mar 26:bloodadvances.2023012430. doi: 10.1182/bloodadvances.2023012430. Online ahead of print. Blood Adv. 2024. PMID: 38607410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,024 results

Search Page